Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Biogen Idec disclosed in its 3Q12 earnings that during the quarter it began a double-blind, placebo-controlled, U.S. Phase Ib trial to evaluate multiple doses of IV BIIB037 in about 120 patients with ...